Next generation sequencing in the diagnosis of Stargardt's disease

• DOI: 10.1016/j.oftale.2017.06.004
• Publication Date: 2017-07-20T03:47:22Z
• Authors: B. Jimenez-Rolando; S. Noval; I. Rosa-Perez; E. Mata Diaz; A. del Pozo; C. Ibañez; J.C. Silla; V.E.F. Montaño; R. Martin-Arenas; E. Vallespin
• Keywords: ABCA4; Stargardt disease; Macular dystrophy

Stargardt's disease is the most frequent form of inherited macular dystrophy in children and adults. It is a genetic eye disorder caused by mutations in ABCA4 gene with an autosomal recessive inheritance. ABCA4 is a very polymorphic and large gene containing 50 exons. The development of next generation sequencing (NGS) can be used for the genetic diagnosis of this disease.A report is presented on two patients with a clinical diagnosis of Stargardt's disease whose genetic confirmation was performed by a NGS panel of 298 genes.Clinically, the patients showed bull's eye maculopathy and absence of flecks, and genetically they shared the Gly1961Glu mutation that could explain their common phenotype, together with c.C3056T:p.T1019M for case 1, and c.287del:p.Asn96Thrfs*19 for case 2.NGS is particularly useful in the diagnosis of Stargardt's disease as ABCA4 is a large gene with a high allelic heterogeneity that causes a wide range of clinical manifestations.